{"id":"W2909427482","doi":"10.1093/annonc/mdy553","title":"Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)","year":2019,"lang":"en","type":"editorial","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Francis Crick Institute","keywords":"Durvalumab; Medicine; Lung cancer; Stage (stratigraphy); Chemoradiotherapy; Oncology; Cancer; Internal medicine; Position paper; Intensive care medicine; Immunotherapy; Pathology; Nivolumab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007075996,0.0002791103,0.001003856,0.0002159115,0.00007736919,0.000009671523,0.0003232495,0.0004153417,0.00002843497],"category_scores_gemma":[0.0007513658,0.0001739332,0.0002715097,0.0001241273,0.0001909732,0.0001010719,0.000058798,0.0002272574,5.836787e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003876973,"about_ca_system_score_gemma":0.001811121,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005998116,"about_ca_topic_score_gemma":0.001193858,"domain_scores_codex":[0.997722,0.00009196784,0.0009455319,0.0004214259,0.0005372136,0.0002818021],"domain_scores_gemma":[0.9918662,0.004178536,0.001348193,0.0004490184,0.002115656,0.00004237795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008352252,0.00139358,0.0008929062,0.001649965,0.001194746,0.000001550118,0.002582029,0.0001528922,0.006344638,0.0001575921,0.9714643,0.00581356],"study_design_scores_gemma":[0.04209283,0.01534958,0.001769584,0.006071582,0.003572253,0.000003124633,0.001519967,0.003516728,0.03977087,0.0001366001,0.8856708,0.000526124],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7130521,0.005645072,0.003647974,0.01218766,0.2122434,0.02731589,0.02545866,0.00002020016,0.0004290335],"genre_scores_gemma":[0.7941886,0.006116346,0.005354456,0.002203186,0.1473427,0.01816201,0.01193074,0.0003854714,0.01431646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08579354,"threshold_uncertainty_score":0.9067396,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09409710497506642,"score_gpt":0.4474031423284522,"score_spread":0.3533060373533858,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}